TO LISTEN TO THE PODCAST CLICK THE PLAY BUTTON BELOW
ON TODAY’S PODCAST:
396 – Nicola Duke Technical Analyst Plus ex-fund manager now private investor Jamie Streeter
Nicola Duke, technical analyst charts:
(click to enlarge)
ALSO….. IT’S A ROLLOVER!!!
Nobody guessed Brent Crude would be exactly $34.74 at midday today so that will be added to $31.10 from last week.
This means $65.84 plus next week’s Brent Crude price could be won by you if you guess the exact price of Brent Crude at midday next Friday. Submissions close at 4:30pm Thursday.
What’s the name AND ticker symbol (include both please) of the stock with potential?
Motif Bio (MTFB)
What does the company do?
Develops new Antibiotics to overcome drug resistant bacteria.
Would you say this is a short / medium / long term investment?
Short-US listing and peer valuation rerate
Medium-Phase 3 trial and Strategic Partner Interest
Long-2018 Iclaprim Commercialization and $1bn sales per annum.
How many shares does the company have in issue?
MTFB Concert Party/AMP hold 39%(April 2916 LockIn)
Institutions have another 55% including Standard Life/Aviva/Invesco
Free Float less than 6%.
What’s current price AND market capitalisation of the company?
Current SP=39.25 and market cap is Â£43.35m
What revenue and profit /loss does the company generate? (if none see next question)
No present revenue but projected $40bn market by 2020 and $1bn global sales.
How much cash or debt does the company have?
Â£20 million cash.
List three reasons why you think this company has potential.
1. Main Asset-Iclaprim a novel antibiotic entering phase 3 with Fastrack/QIDP approval entering a huge market( global crisis and massive need for new antibiotics)
2. Great management both commercial and scientific experience of taking multi billion pound company’s to BASDAQ(Celgene) and running global operations(Merck).
The post 396 – Nicola Duke Technical Analyst Plus ex-fund manager now private investor Jamie Streeter appeared first on SharePickers.com.